866-997-4948(US-Canada Toll Free)

Global Drugs for Malaria Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 113 Pages

This report studies the global market size of Drugs for Malaria in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Malaria in these regions.
This research report categorizes the global Drugs for Malaria market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.


The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
In 2017, the global Drugs for Malaria market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Drugs for Malaria market based on company, product type, application and key regions.

The various contributors involved in the value chain of Drugs for Malaria include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Drugs for Malaria include
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

Market Size Split by Type
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Market Size Split by Application
Prevention
Treatment
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drugs for Malaria market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Drugs for Malaria market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs for Malaria manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drugs for Malaria with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Drugs for Malaria submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drugs for Malaria are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Malaria market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Drugs for Malaria Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Drugs for Malaria Market Size Growth Rate by Type
1.4.2 Aryl Aminoalcohol Compounds
1.4.3 Antifolate Compounds
1.4.4 Artemisinin Compounds
1.5 Market by Application
1.5.1 Global Drugs for Malaria Market Size Growth Rate by Application
1.5.2 Prevention
1.5.3 Treatment
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drugs for Malaria Market Size
2.1.1 Global Drugs for Malaria Revenue 2016-2025
2.1.2 Global Drugs for Malaria Sales 2016-2025
2.2 Drugs for Malaria Growth Rate by Regions
2.2.1 Global Drugs for Malaria Sales by Regions
2.2.2 Global Drugs for Malaria Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Drugs for Malaria Sales by Manufacturers
3.1.1 Drugs for Malaria Sales by Manufacturers
3.1.2 Drugs for Malaria Sales Market Share by Manufacturers
3.1.3 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)
3.2 Drugs for Malaria Revenue by Manufacturers
3.2.1 Drugs for Malaria Revenue by Manufacturers (2016-2018)
3.2.2 Drugs for Malaria Revenue Share by Manufacturers (2016-2018)
3.3 Drugs for Malaria Price by Manufacturers
3.4 Drugs for Malaria Manufacturing Base Distribution, Product Types
3.4.1 Drugs for Malaria Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drugs for Malaria Product Category
3.4.3 Date of International Manufacturers Enter into Drugs for Malaria Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Drugs for Malaria Sales by Type
4.2 Global Drugs for Malaria Revenue by Type
4.3 Drugs for Malaria Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Drugs for Malaria Breakdown Data by Application

6 North America
6.1 North America Drugs for Malaria by Countries
6.1.1 North America Drugs for Malaria Sales by Countries
6.1.2 North America Drugs for Malaria Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Drugs for Malaria by Type
6.3 North America Drugs for Malaria by Application
6.4 North America Drugs for Malaria by Company

7 Europe
7.1 Europe Drugs for Malaria by Countries
7.1.1 Europe Drugs for Malaria Sales by Countries
7.1.2 Europe Drugs for Malaria Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drugs for Malaria by Type
7.3 Europe Drugs for Malaria by Application
7.4 Europe Drugs for Malaria by Company

8 Asia Pacific
8.1 Asia Pacific Drugs for Malaria by Countries
8.1.1 Asia Pacific Drugs for Malaria Sales by Countries
8.1.2 Asia Pacific Drugs for Malaria Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Drugs for Malaria by Type
8.3 Asia Pacific Drugs for Malaria by Application
8.4 Asia Pacific Drugs for Malaria by Company

9 Central & South America
9.1 Central & South America Drugs for Malaria by Countries
9.1.1 Central & South America Drugs for Malaria Sales by Countries
9.1.2 Central & South America Drugs for Malaria Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Drugs for Malaria by Type
9.3 Central & South America Drugs for Malaria by Application
9.4 Central & South America Drugs for Malaria by Company

10 Middle East and Africa
10.1 Middle East and Africa Drugs for Malaria by Countries
10.1.1 Middle East and Africa Drugs for Malaria Sales by Countries
10.1.2 Middle East and Africa Drugs for Malaria Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Drugs for Malaria by Type
10.3 Middle East and Africa Drugs for Malaria by Application
10.4 Middle East and Africa Drugs for Malaria by Company

11 Company Profiles
11.1 Cipla
11.1.1 Cipla Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.1.4 Drugs for Malaria Product Description
11.1.5 Recent Development
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.2.4 Drugs for Malaria Product Description
11.2.5 Recent Development
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.3.4 Drugs for Malaria Product Description
11.3.5 Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.4.4 Drugs for Malaria Product Description
11.4.5 Recent Development
11.5 Mylan Labs
11.5.1 Mylan Labs Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.5.4 Drugs for Malaria Product Description
11.5.5 Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.6.4 Drugs for Malaria Product Description
11.6.5 Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.7.4 Drugs for Malaria Product Description
11.7.5 Recent Development
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.8.4 Drugs for Malaria Product Description
11.8.5 Recent Development
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Drugs for Malaria
11.9.4 Drugs for Malaria Product Description
11.9.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Drugs for Malaria Raw Material
13.1.2 Drugs for Malaria Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Drugs for Malaria
Figure Global Drugs for Malaria Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Drugs for Malaria Production Market Share by Types (Product Category) in 2017
Figure Aryl Aminoalcohol Compounds Product Picture
Table Major Manufacturers of Aryl Aminoalcohol Compounds
Figure Antifolate Compounds Product Picture
Table Major Manufacturers of Antifolate Compounds
Figure Artemisinin Compounds Product Picture
Table Major Manufacturers of Artemisinin Compounds
Table Global Drugs for Malaria Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Prevention
Figure Treatment
Figure Other
Figure Drugs for Malaria Report Years Considered
Figure Global Drugs for Malaria Market Size 2016-2025 (Million US$)
Figure Global Drugs for Malaria Sales 2016-2025 (K Units)
Table Global Drugs for Malaria Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Drugs for Malaria Sales by Regions 2016-2025 (K Units)
Table Global Drugs for Malaria Sales Market Share by Regions 2016-2025
Figure Global Drugs for Malaria Sales Market Share by Regions 2016-2025
Figure 2017 Global Drugs for Malaria Sales Market Share by Regions
Table Global Drugs for Malaria Revenue by Regions 2016-2025 (Million US$)
Table Global Drugs for Malaria Revenue Market Share by Regions 2016-2025
Figure Global Drugs for Malaria Revenue Market Share by Regions 2016-2025
Figure 2017 Global Drugs for Malaria Revenue Market Share by Regions
Table Global Drugs for Malaria Sales by Manufacturers (2016-2018) (K Units)
Table Global Drugs for Malaria Sales Share by Manufacturers (2016-2018)
Figure Global Drugs for Malaria Sales Share by Manufacturers in 2017
Table Drugs for Malaria Revenue by Manufacturers (2016-2018) (Million US$)
Table Drugs for Malaria Revenue Share by Manufacturers (2016-2018)
Figure Drugs for Malaria Value Share by Manufacturers in 2017
Table Global Drugs for Malaria Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Drugs for Malaria Price (2016-2018) (USD/Unit)
Table Drugs for Malaria Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Drugs for Malaria Product Category
Table Date of International Manufacturers Enter into Drugs for Malaria Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Drugs for Malaria Sales by Type (2016-2025) (K Units)
Table Global Drugs for Malaria Sales Share by Type (2016-2025)
Figure Global Drugs for Malaria Sales Market Share by Type (2016-2025)
Figure Global Drugs for Malaria Sales Market Share by Type in 2017
Table Global Drugs for Malaria Revenue by Type (2016-2025) (Million US$)
Table Global Drugs for Malaria Revenue Share by Type (2016-2025)
Figure Global Drugs for Malaria Revenue Market Share by Type (2016-2025)
Figure Global Drugs for Malaria Revenue Market Share by Type in 2017
Table Drugs for Malaria Price by Type 2013-2018 (USD/Unit)
Table Global Drugs for Malaria Sales by Application (2016-2025) (K Units)
Table Global Drugs for Malaria Sales Share by Application (2016-2025)
Figure Global Sales Drugs for Malaria Market Share by Application (2016-2025)
Figure Global Sales Drugs for Malaria Market Share by Application (2016-2025)
Figure North America Drugs for Malaria Sales Growth Rate 2016-2025 (K Units)
Figure North America Drugs for Malaria Revenue Growth Rate 2016-2025 (Million US$)
Table North America Drugs for Malaria Sales by Countries (2016-2025) (K Units)
Table North America Drugs for Malaria Sales Market Share by Countries (2016-2025)
Figure 2017 North America Drugs for Malaria Sales Market Share by Countries
Table North America Drugs for Malaria Revenue by Countries (2016-2025) (Million US$)
Table North America Drugs for Malaria Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Drugs for Malaria Revenue Market Share by Countries
Figure United States Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure United States Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Canada Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Table North America Drugs for Malaria Sales by Type (2016-2025) (K Units)
Table North America Drugs for Malaria Sales Market Share by Type (2016-2025)
Figure 2017 North America Drugs for Malaria Market Share by Type
Table North America Drugs for Malaria Sales by Application (2016-2025) (K Units)
Table North America Drugs for Malaria Sales Market Share by Application (2016-2025)
Figure 2017 North America Drugs for Malaria Market Share by Application
Table North America Drugs for Malaria Sales by Company (2016-2018) (K Units)
Table North America Drugs for Malaria Sales Market Share by Company (2016-2018)
Figure North America Drugs for Malaria Sales Market Share by Company in 2017
Figure Europe Drugs for Malaria Sales Growth Rate 2016-2025 (K Units)
Figure Europe Drugs for Malaria Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Drugs for Malaria Sales by Countries (2016-2025) (K Units)
Table Europe Drugs for Malaria Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Drugs for Malaria Sales Market Share by Countries
Table Europe Drugs for Malaria Revenue by Countries (2016-2025) (Million US$)
Table Europe Drugs for Malaria Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Drugs for Malaria Revenue Market Share by Countries
Figure Germany Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Germany Drugs for Malaria Revenue Growth Rate (2016-2025) (K Units)
Figure France Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure France Drugs for Malaria Revenue Growth Rate (2016-2025) (K Units)
Figure UK Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure UK Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Italy Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Russia Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Drugs for Malaria Sales by Type (2016-2025) (K Units)
Table Europe Drugs for Malaria Sales Market Share by Type (2016-2025)
Figure 2017 Europe Drugs for Malaria Market Share by Type
Table Europe Drugs for Malaria Sales by Application (2016-2025) (K Units)
Table Europe Drugs for Malaria Sales Market Share by Application (2016-2025)
Figure 2017 Europe Drugs for Malaria Market Share by Application
Table Europe Drugs for Malaria Sales by Company (2016-2018) (K Units)
Table Europe Drugs for Malaria Sales Market Share by Company (2016-2018)
Figure Europe Drugs for Malaria Sales Market Share by Company in 2017
Figure Asia Pacific Drugs for Malaria Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Drugs for Malaria Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Drugs for Malaria Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Drugs for Malaria Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Drugs for Malaria Sales Market Share by Countries
Table Asia Pacific Drugs for Malaria Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Drugs for Malaria Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Drugs for Malaria Revenue Market Share by Countries
Figure China Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure China Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Japan Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Korea Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure India Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure India Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Australia Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Drugs for Malaria Sales by Type (2016-2025) (K Units)
Table Asia Pacific Drugs for Malaria Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Drugs for Malaria Market Share by Type
Table Asia Pacific Drugs for Malaria Sales by Application (2016-2025) (K Units)
Table Asia Pacific Drugs for Malaria Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Drugs for Malaria Market Share by Application
Table Asia Pacific Drugs for Malaria Sales by Company (2016-2018) (K Units)
Table Asia Pacific Drugs for Malaria Sales Market Share by Company (2016-2018)
Figure Asia Pacific Drugs for Malaria Sales Market Share by Company in 2017
Figure Central & South America Drugs for Malaria Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Drugs for Malaria Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Drugs for Malaria Sales by Countries (2016-2025) (K Units)
Table Central & South America Drugs for Malaria Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Drugs for Malaria Sales Market Share by Countries
Table Central & South America Drugs for Malaria Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Drugs for Malaria Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Drugs for Malaria Revenue Market Share by Countries
Figure Brazil Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Drugs for Malaria Sales by Type (2016-2025) (K Units)
Table Central & South America Drugs for Malaria Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Drugs for Malaria Market Share by Type
Table Central & South America Drugs for Malaria Sales by Application (2016-2025) (K Units)
Table Central & South America Drugs for Malaria Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Drugs for Malaria Market Share by Application
Table Central & South America Drugs for Malaria Sales by Company (2016-2018) (K Units)
Table Central & South America Drugs for Malaria Sales Market Share by Company (2016-2018)
Figure Central & South America Drugs for Malaria Sales Market Share by Company in 2017
Figure Middle East and Africa Drugs for Malaria Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Drugs for Malaria Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Drugs for Malaria Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Drugs for Malaria Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Drugs for Malaria Sales Market Share by Countries
Table Middle East and Africa Drugs for Malaria Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Drugs for Malaria Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Drugs for Malaria Revenue Market Share by Countries
Figure GCC Countries Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Drugs for Malaria Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Drugs for Malaria Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Drugs for Malaria Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Drugs for Malaria Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Drugs for Malaria Market Share by Type
Table Middle East and Africa Drugs for Malaria Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Drugs for Malaria Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Drugs for Malaria Market Share by Application
Table Middle East and Africa Drugs for Malaria Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Drugs for Malaria Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Drugs for Malaria Sales Market Share by Company in 2017
Table Cipla Company Details
Table Cipla Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Cipla Recent Development
Table Guilin Pharmaceutical Company Details
Table Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Guilin Pharmaceutical Recent Development
Table IPCA Laboratories Company Details
Table IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table IPCA Laboratories Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Mylan Labs Company Details
Table Mylan Labs Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mylan Labs Recent Development
Table Roche Company Details
Table Roche Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Sanofi Aventis Company Details
Table Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Aventis Recent Development
Table Ajanta Pharma Company Details
Table Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Ajanta Pharma Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Drugs for Malaria Value Chain
Table Typical Suppliers of Key Drugs for Malaria Raw Material
Table Drugs for Malaria Customers List
Table Drugs for Malaria Sales Channels
Table Drugs for Malaria Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *